MAR 24, 2016 11:23 AM PDT

New Gene Player Identified in Breast Cancer

WRITTEN BY: Xuan Pham
GT198 mutations could lead to new target for breast cancer diagnosis and therapy

There’s a new gene player in breast cancer, and it’s called GT198. Already known to be mutated in early onset breast and ovarian cancer, researchers now show that mutation of GT198 in breast progenitor cells can induce tumor formation. This genetic player represents potentially new ways to diagnose and target breast cancer.

Dr. Nahid Mivechi, Dr. Nita Maihle, Dr. Lan KoThe gene GT198, also known as PSMC3IP, encodes a protein that functions in meiotic recombination and DNA repair. More pertinent to breast cancer, GT198 protein products activate other genes in the presence of the hormone estrogen. Mutations in GT198 cause the gene to function even in the absence of estrogen signals. "Regardless of how much hormone you have, it's out-of-control growth," said Lan Ko, cancer biologist at the Medical College of Georgia (MCG) at Augusta University, and senior study author.
 
In a sampling of 249 cases of breast cancer tissues in pre- and postmenopausal women, the team found GT198 protein in breast stromal tissues but not in the 11 healthy tissue controls. "This gene mutation can be in both the blood and the tumor tissue of patients, and in the tissue, it's in high percentages," said Ko. "We believe that once this gene is mutated, it induces the tumor to grow."
 
Stromal tissues is made up of a collection of cells, including fat cells and connective tissues, that provide padding and structural support for the ductal system in the breast. Researchers have previously observed changes in the stroma for breast cancer patients, but they did not know the genetic cause. That the GT198 protein was found in stromal tissue provided the ‘smoking gun’ researchers were hoping to find.
 
"This puts it together," Ko said, referring to the mutation of GT198 in the breast precursor cells that then make up the various components of the stroma. It’s thought that the mutated form of GT198 stimulates blood vessel growth and fat production – activities that create a more favorable environment for breast cancer to proliferate.
 

"It's a new target in cancer. It's very exciting," said Nita Maihle, MCG cancer biologist and a study co-author. "This tells you that all the different types of stromal cells in breast tissue are affected by the GT198 mutation because they all come from a common progenitor cell."
 
A major consequence of this finding is the potential for GT198 to be a new target in breast cancer therapy. A drug that directly blocks GT198 protein in progenitor cells would have the capacity to be very effective, as it would nip cancer where it begins. "We think the way to treat breast cancer is to target the progenitor cells. We want to kill these cells that are feeding the tumor rather than just killing the tumor cells, which is less effective,” said Ko.
 
Another consequence of this discovery is the potential for GT198 to be a new biomarker in ductal breast cancer. Detecting stromal cells that are positive for the GT198 mutations and expression the protein could enhance diagnosis of cancer in the early stages. 

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 19, 2019
Cancer
OCT 19, 2019
How cancer tricks our immune systems
Research published yesterday in Nature details the finding of a new “Don’t eat me” signal that cancers use to hide from the body’s ...
OCT 19, 2019
Cancer
OCT 19, 2019
Could electromagnetic fields treat metastatic triple-negative breast cancer?
New research published in Communications Biology suggests that electromagnetic fields are capable of stopping the metastasis of some breast cancer cells. I...
OCT 19, 2019
Cardiology
OCT 19, 2019
Childhood Cancer Survivors Prone to Cardiac Events
A new study published in the American Heart Association's journal Circulation explores the relationship between childhood cancer, metabolic conditions ...
OCT 19, 2019
Cancer
OCT 19, 2019
Not the fried food!
Stop! Put down those fries! Although we know that fried foods aren’t good for our health (though they sure do taste good!), new research from UMass A...
OCT 19, 2019
Immunology
OCT 19, 2019
New Observations of a Cancer Transcriptase
New research shows a transcriptase that helps time cell death varies in expression, and is unusually localized, in cancer cells.  The transcriptase, T...
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Promising Drug for Prostate Cancer
Using high-throughput screening methods, cancer researchers from the UK have identified some promising drug candidates to test thousands of molecules. Spec...
Loading Comments...